Quarter Financials
TG Therapeutics, Inc. (TGTX)
$25.92
-0.57 (-2.15%)
Income Statement
Balance Sheet
Cash Flow
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
Net Income | -53 | -36 | -41 | -69 | -93 | -86 | -78 | -91 |
Dividend Paid | - | - | - | - | - | - | - | - |
Retained Earnings | -1,527 | -1,474 | -1,438 | -1,398 | -1,329 | -1,235 | -1,150 | -1,071 |
---|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
Capital Expenditure | - | - | - | -0 | -0 | -0 | -0 | -0 |
Net PPE | 9 | 9 | 11 | 11 | 11 | 11 | 12 | 12 |
---|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
New Purchases | -17 | -14 | -12 | -12 | -57 | -15 | - | - |
Intangible and Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
---|